Back
Dermata Therapeutics Stock Price Chart
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
20
DRMA
Dermata Therapeutics
Last Price:
1.16
Seasonality Move:
-57.39%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing selling pressure, which indicates risk of future bearish movement.
Dermata Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.31 | Sell |
| 20-day SMA: | 1.39 | Sell |
| 50-day SMA: | 1.49 | Sell |
| 200-day SMA: | 3.56 | Sell |
| 8-day EMA: | 1.31 | Sell |
| 20-day EMA: | 1.36 | Sell |
| 50-day EMA: | 1.54 | Sell |
| 200-day EMA: | 6.55 | Sell |
Dermata Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 39.82 | Sell |
| Chaikin Money Flow: | -47640 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.27 - 1.49) | Sell |
| Bollinger Bands (100): | (1.37 - 2.27) | Sell |
Dermata Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dermata Therapeutics Stock
Is Dermata Therapeutics Stock a Buy?
- Dermata Therapeutics share price is 1.23 while DRMA 8-day simple moving average is 1.31, which is a Sell signal.
- The stock price of DRMA is 1.23 while Dermata Therapeutics 20-day SMA is 1.39, which makes it a Sell.
- Dermata Therapeutics 50-day simple moving average is 1.49 while DRMA share price is 1.23, making it a Sell technically.
- DRMA stock price is 1.23 and Dermata Therapeutics 200-day simple moving average is 3.56, creating a Sell signal.
DRMA Technical Analysis vs Fundamental Analysis
Sell
20
Dermata Therapeutics (DRMA)
is a Sell
Is Dermata Therapeutics a Buy or a Sell?
-
Dermata Therapeutics stock is rated a Sell
The current Dermata Therapeutics [DRMA] share price is $1.23. The Score for DRMA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Dermata Therapeutics Stock Info
Market Cap:
1.62M
Price in USD:
1.23
Share Volume:
47.64K
Dermata Therapeutics 52-Week Range
52-Week High:
14.63
52-Week Low:
1.20
Sell
20
Dermata Therapeutics (DRMA)
is a Sell
Dermata Therapeutics Share Price Forecast
-
What is the Dermata Therapeutics stock price today?
The Dermata Therapeutics stock price is 1.23 USD today. -
Will DRMA stock go up or go down?
Dermata Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Dermata Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dermata Therapeutics is overvalued.
Is Dermata Therapeutics Stock a Buy?
- Dermata Therapeutics share price is 1.23 while DRMA 8-day exponential moving average is 1.31, which is a Sell signal.
- The stock price of DRMA is 1.23 while Dermata Therapeutics 20-day EMA is 1.36, which makes it a Sell.
- Dermata Therapeutics 50-day exponential moving average is 1.54 while DRMA share price is 1.23, making it a Sell technically.
- DRMA stock price is 1.23 and Dermata Therapeutics 200-day simple moving average is 6.55, creating a Sell signal.
Technical Analysis of Dermata Therapeutics
Should I short Dermata Therapeutics stock?
- DRMA Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Dermata Therapeutics is a Sell
- Dermata Therapeutics Relative Strength Index (RSI) is 39.82, which suggest Dermata Therapeutics is oversold
- The Bollinger Bands (25) for Dermata Therapeutics is (1.27 - 1.49), which suggest Dermata Therapeutics is a Sell
- The Bollinger Bands (100) for Dermata Therapeutics is (1.37 - 2.27), which suggest Dermata Therapeutics is a Sell
* Dermata Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.